Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 10.50% is 16% below its 5-year average of 12.57%, near the low end of its 5-year range (10.50%–13.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 13.01% below its 12-month average of 12.07%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.50%.
DEBT TO ASSETS RATIO
10.50%
DEBT TO ASSETS RATIO AVG TTM
12.07%
DEBT TO ASSETS RATIO AVG 3Y
12.54%
DEBT TO ASSETS RATIO AVG 5Y
12.57%
DEBT TO ASSETS RATIO AVG 10Y
12.88%
DEBT TO ASSETS RATIO AVG 15Y
12.99%
DEBT TO ASSETS RATIO AVG 20Y
10.91%
CURRENT VS TTM AVG
-13.01%
CURRENT VS 3Y AVG
-16.28%
CURRENT VS 5Y AVG
-16.46%
CURRENT VS 10Y AVG
-18.46%
CURRENT VS 15Y AVG
-19.17%
CURRENT VS 20Y AVG
-3.74%
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 530 covered companies
CURRENT VS SECTOR MEDIAN
+9900.07%
vs the sector median at left
AtriCure, Inc.
Market Cap
$2.87B
Debt to Assets Ratio
10.50%
TTM Avg
12.07%
3Y Avg
12.54%
5Y Avg
12.57%
Market Cap
$2.86B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.89B
Debt to Assets Ratio
0.59%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.72B
Debt to Assets Ratio
0.71%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.71B
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.70B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.69B
Debt to Assets Ratio
0.46%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.08B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.65B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AtriCure, Inc. (ATRC) | $2.87B | 10.50% | 12.07% | 12.54% | 12.57% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.86B | 0.02% | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.89B | 0.59% | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.72B | 0.71% | N/A | N/A | N/A |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.71B | 0.13% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.70B | 0.18% | N/A | N/A | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 0.46% | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.08B | 0.02% | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.65B | 0.05% | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.11B | 0.02% | N/A | N/A | N/A |
Debt/Assets
10.5%
Debt/Equity
0.14
Current Ratio
4.22
Interest Coverage
-0.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 10.50% |
| 2026-03-31 | 11.63% |
| 2025-12-31 | 13.45% |
| 2025-09-30 | 12.08% |
| 2025-06-30 | 12.69% |
| 2025-03-31 | 13.08% |
| 2024-12-31 | 12.56% |
| 2024-09-30 | 12.54% |
| 2024-06-30 | 12.61% |
| 2024-03-31 | 12.74% |
| 2023-12-31 | 12.13% |
| 2023-09-30 | 12.39% |
| 2023-06-30 | 12.59% |
| 2023-03-31 | 12.90% |
| 2022-12-31 | 12.73% |
| 2022-09-30 | 12.86% |
| 2022-06-30 | 12.76% |
| 2022-03-31 | 12.88% |
| 2021-12-31 | 12.29% |
| 2021-09-30 | 11.88% |
| 2021-06-30 | 10.63% |
| 2021-03-31 | 10.51% |
| 2020-12-31 | 10.36% |
| 2020-09-30 | 10.53% |
| 2020-06-30 | 10.62% |
| 2020-03-31 | 14.41% |
| 2019-12-31 | 13.70% |
| 2019-09-30 | 13.63% |
| 2019-06-30 | 15.69% |
| 2019-03-31 | 15.99% |
| 2018-12-31 | 14.70% |
| 2018-09-30 | 19.29% |
| 2018-06-30 | 19.38% |
| 2018-03-31 | 19.47% |
| 2017-12-31 | 13.98% |
| 2017-09-30 | 14.41% |
| 2017-06-30 | 14.44% |
| 2017-03-31 | 14.57% |
| 2016-12-31 | 14.07% |
| 2016-09-30 | 13.94% |
| 2016-06-30 | 13.83% |
| 2016-03-31 | 5.37% |
| 2015-12-31 | 5.19% |
| 2015-09-30 | 8.23% |
| 2015-06-30 | 5.84% |
| 2015-03-31 | 3.96% |
| 2014-12-31 | 2.56% |
| 2014-09-30 | 1.65% |
| 2014-06-30 | 0.07% |
| 2014-03-31 | 0.07% |
| 2013-12-31 | 5.76% |
| 2013-09-30 | 12.07% |
| 2013-06-30 | 12.91% |
| 2013-03-31 | 13.64% |
| 2012-12-31 | 26.01% |
| 2012-09-30 | 26.38% |
| 2012-06-30 | 26.11% |
| 2012-03-31 | 27.10% |
| 2011-12-31 | 19.10% |
| 2011-09-30 | 19.99% |
| 2011-06-30 | 19.94% |
| 2011-03-31 | 20.66% |
| 2010-12-31 | 8.47% |
| 2010-09-30 | 9.46% |
| 2010-06-30 | 11.18% |
| 2010-03-31 | 13.32% |
| 2009-12-31 | 14.00% |
| 2009-09-30 | 14.68% |
| 2009-06-30 | 16.62% |
| 2009-03-31 | 0.22% |
| 2008-12-31 | 14.00% |
| 2008-09-30 | 13.32% |
| 2008-06-30 | 1.41% |
| 2008-03-31 | 1.57% |
| 2007-12-31 | 2.40% |
| 2007-09-30 | 1.74% |
| 2007-06-30 | 1.79% |
| 2007-03-31 | 2.73% |
| 2006-12-31 | 2.77% |
| 2006-09-30 | 2.84% |
| 2006-06-30 | 2.88% |
| 2006-03-31 | 2.90% |
| 2005-12-31 | 2.96% |
| 2005-09-30 | 2.89% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
